Louisiana State Employees Retirement System Invests $2.35 Million in Masimo Corporation $MASI

Louisiana State Employees Retirement System purchased a new stake in Masimo Corporation (NASDAQ:MASI) in the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 13,200 shares of the medical equipment provider’s stock, valued at approximately $2,348,000.

A number of other institutional investors have also modified their holdings of the business. Massachusetts Financial Services Co. MA lifted its holdings in Masimo by 1.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock worth $346,464,000 after acquiring an additional 43,915 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in shares of Masimo by 9.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock valued at $303,061,000 after purchasing an additional 203,395 shares during the last quarter. Naya Capital Management UK Ltd. acquired a new stake in shares of Masimo during the 4th quarter worth approximately $202,984,000. Westfield Capital Management Co. LP raised its position in shares of Masimo by 7.2% during the 4th quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock worth $197,958,000 after purchasing an additional 102,799 shares during the period. Finally, State Street Corp lifted its holdings in shares of Masimo by 0.7% in the 2nd quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock worth $250,041,000 after purchasing an additional 10,403 shares during the last quarter. Institutional investors own 85.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Raymond James Financial lowered Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Finally, Wells Fargo & Company upgraded Masimo to a “hold” rating in a research note on Wednesday, March 18th. Nine analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $180.40.

Masimo Price Performance

Shares of NASDAQ:MASI opened at $179.95 on Tuesday. The firm’s 50 day moving average is $179.03 and its two-hundred day moving average is $163.58. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $179.99. The firm has a market capitalization of $9.42 billion, a P/E ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.